Neuren Pharmaceuticals Ltd
NEU
Company Profile
Business description
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.
Contact
697 Burke Road
Suite 201
Camberwell
Melbourne VIC 3124
AUST: +61 390920480
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
15
Stocks News & Analysis
stocks
5 top US dividend shares from the best managers
These cheap dividend stocks are popular among highly rated concentrated fund managers.
stocks
Undervalued ASX company announces turnaround plan for lagging operations
Two key markets are hurting results but there is no quick fix.
video
Our view of Australian banks
Our latest banking industry pulse explored the state of the industry.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,862.30 | 147.10 | -1.84% |
| CAC 40 | 7,931.55 | 113.56 | -1.41% |
| DAX 40 | 17,798.94 | 227.64 | -1.26% |
| Dow JONES (US) | 37,735.11 | 248.13 | -0.65% |
| FTSE 100 | 7,868.43 | 97.10 | -1.22% |
| HKSE | 16,250.31 | 350.15 | -2.11% |
| NASDAQ | 15,885.02 | 290.08 | -1.79% |
| Nikkei 225 | 38,471.20 | 761.60 | -1.94% |
| NZX 50 Index | 11,804.84 | 111.94 | -0.94% |
| S&P 500 | 5,061.82 | 61.59 | -1.20% |
| S&P/ASX 200 | 7,612.50 | 140.00 | -1.81% |
| SSE Composite Index | 3,007.07 | 50.31 | -1.65% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.07 | -14.43% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | -7.89% |
| Imugene Ltd IMU | 0.08 | 0.01 | -8.79% |
| Zip Co Ltd ZIP | 1.19 | 0.15 | -10.90% |
| Resolute Mining Ltd RSG | 0.43 | 0.06 | -12.24% |
| Telstra Group Ltd TLS | 3.68 | 0.03 | -0.81% |
| Peninsula Energy Ltd PEN | 0.10 | 0.01 | -6.67% |
| Piedmont Lithium Inc PLL | 0.22 | 0.07 | -22.81% |
| Core Lithium Ltd CXO | 0.14 | 0.02 | -9.68% |
| South32 Ltd S32 | 3.28 | 0.16 | -4.65% |